CEP-2563 tyrosine kinase receptor inhibitor: Collaborator TAP Holdings Inc. began a Phase I

Cephalon Inc. (CEPH), West Chester, Penn. Product: CEP-2563 tyrosine kinase receptor inhibitor Indication: Prostate and other cancers Status: Collaborator TAP Holdings Inc. began a Phase I dose-escala...